Literature DB >> 31808294

Pure Laparoscopic Versus Open Left Hepatectomy Including the Middle Hepatic Vein for Living Donor Liver Transplantation.

Suk Kyun Hong1, Kyung-Suk Suh1, Kyung Ae Kim1, Jeong-Moo Lee1, Jae-Hyung Cho1, Nam-Joon Yi1, Kwang-Woong Lee1.   

Abstract

Pure laparoscopic donor hepatectomy (PLDH) has become increasingly accepted in the era of minimally invasive surgeries. However, the outcomes of pure laparoscopic donor left hepatectomy (PLDLH) are relatively less known than for left lateral sectionectomy or right hepatectomy. This study aimed to report our experience with and the outcomes of PLDLH including the middle hepatic vein (MHV) and to compare these outcomes with conventional donor left hepatectomy (CDLH). The medical records of living liver donors between January 2010 and January 2018 at Seoul National University Hospital were retrospectively reviewed. Donors who underwent left hepatectomy including the MHV were included. To minimize selection bias, donors who underwent CDLH after the initiation of the PLDH program were excluded. Finally, there were 18 donors who underwent CDLH and 8 who underwent PLDLH. The median (interquartile range [IQR]) warm ischemia time (11 [10-16] minutes versus 4 [2-7] minutes; P = 0.001) was longer in the PLDLH group than the CDLH group. The total operation time (333 [281-376] minutes versus 265 [255-308] minutes; P = 0.09) and time to remove the liver (245 [196-276] minutes versus 182 [172-205] minutes; P = 0.08) were also longer in PLDLH although not statistically significant. The length of postoperative hospital stay was significantly shorter in the PLDLH group (7 [7-8] days versus 9 [8-10] days; P = 0.01). There were no postoperative complications in the PLDLH group. The rate of complications in recipients was similar in both groups. In conclusion, PLDLH including the MHV appears to be safe and feasible. Further analysis including longterm outcomes is needed.
Copyright © 2019 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2020        PMID: 31808294     DOI: 10.1002/lt.25697

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  5 in total

Review 1.  Comparison of laparoscopic and open living donor hepatectomy: A meta-analysis.

Authors:  Yuye Gao; Wu Wu; Chunyu Liu; Tao Liu; Heng Xiao
Journal:  Medicine (Baltimore)       Date:  2021-08-13       Impact factor: 1.817

Review 2.  Robotic Living Donor Right Hepatectomy: A Systematic Review and Meta-Analysis.

Authors:  Eddy P Lincango Naranjo; Estefany Garces-Delgado; Timo Siepmann; Lutz Mirow; Paola Solis-Pazmino; Harold Alexander-Leon; Gabriela Restrepo-Rodas; Rafael Mancero-Montalvo; Cristina J Ponce; Ramiro Cadena-Semanate; Ronnal Vargas-Cordova; Glenda Herrera-Cevallos; Sebastian Vallejo; Carolina Liu-Sanchez; Larry J Prokop; Ioannis A Ziogas; Michail G Vailas; Alfredo D Guerron; Brendan C Visser; Oscar J Ponce; Andrew S Barbas; Dimitrios Moris
Journal:  J Clin Med       Date:  2022-05-05       Impact factor: 4.964

Review 3.  Pure laparoscopic versus open donor hepatectomy for adult living donor liver transplantation - A systematic review and meta-analysis.

Authors:  Michail Papoulas; Abdul Rahman Hakeem; Nigel Heaton; Krishna V Menon
Journal:  J Minim Access Surg       Date:  2022 Jan-Mar       Impact factor: 1.407

4.  Pure laparoscopic versus open right donor hepatectomy including the middle hepatic vein: a comparison of outcomes and safety.

Authors:  Jae Hyun Park; Sanggyun Suh; Suk Kyun Hong; Sola Lee; Su Young Hong; YoungRok Choi; Nam-Joon Yi; Kwang-Woong Lee; Kyung-Suk Suh
Journal:  Ann Surg Treat Res       Date:  2022-07-07       Impact factor: 1.766

Review 5.  Laparoscopic living-donor hepatectomy: Review of its current status.

Authors:  Shigeru Marubashi; Hiroaki Nagano
Journal:  Ann Gastroenterol Surg       Date:  2021-03-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.